Monotherapy versus polytherapy of enoxaparin and hydroxychloroquine for the treatment of COVID-19: A randomized controlled clinical trial. Pharm Pract (Granada) [Internet]. 2023 Mar. 30 [cited 2025 Oct. 29];21(1):1-7. Available from: https://www.pharmacypractice.org/index.php/pp/article/view/2777